BridgeMD
New treatment option for Iodine Deficiency
Official title EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
ClinicalTrials.gov ID: NCT06769009
What this study is testing
- What it's testing
- In EUthyroid2 intervention measures are to be developed, implemented in ambulatory care settings and evaluated to effectively raise awareness for the risks of iodine deficiency among young women (18-24 years) in three European countries (Norway, Poland, UK) as well as Bangladesh and Pakistan. A cluster-randomized controlled trial with three points of measurements will be applied in each participating country.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 24, women only. Healthy volunteers may be eligible.
You may be able to join if
- non-pregnant Female
- Age 18-24 years at the time point of recruitment
- Attending the specified settings
- Sufficient language skills to understand the study information, informed consent and the questionnaire
You likely can't join if
- Having a thyroid disease
- Pregnancy at the timepoint of recruitment and during the intervention period
- Lactation
The study team makes the final eligibility decision.
Where it's taking place
- Dhaka, Bangladesh
- Bergen, Bergen, Norway
- Peshawar, Khyber Pakhtunkhwa, Pakistan
- Krakow, Poland
- Belfast, United Kingdom
- Guildford, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 24 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhaka, Bangladesh; Bergen, Bergen, Norway; Peshawar, Khyber Pakhtunkhwa, Pakistan; Krakow, Poland; Belfast, United Kingdom; Guildford, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.